Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Personalized medicine for non-small-cell lung cancer.

Expert review of anticancer therapy - 1 Oct 2010

Mok Tony S, Zhou Qing, Leung Linda, Loong Herbert H

Abstract excerpt

Non-small-cell lung cancer (NSCLC) is a heterogeneous illness associated with a high mortality rate. Personalized therapy may improve treatment outcomes by identification of a specific genotypic anomaly and target-specific therapy. The most significant development in recent years was the discovery of activated EGF receptor (EGFR) mutations at exons 19 and 21. Patients with EGFR mutations respond dramatically to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to Disease-Free Survival

Share to ErbB Receptors

Share to Molecular Targeted Therapy

Share to Precision Medicine

Share to Protein Kinase Inhibitors

Source

Identifiers

PMID: 20942631
DOI: 10.1586/era.10.76

Genes

EGFR
EGF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalized medicine for non-small-cell lung cancer.PMID 20942631Read ↗

Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management.Semantic proximity Read ↗

Personalized targeted therapy for lung cancer.Semantic proximity Read ↗

Personalizing therapy in advanced non-small cell lung cancer.Semantic proximity Read ↗

Personalized targeted therapy in advanced non-small cell lung cancer.Semantic proximity Read ↗

Recent Advances in Personalized Lung Cancer MedicineSemantic proximity Read ↗

Personalized Therapy of Non-small Cell Lung Cancer (NSCLC).Semantic proximity Read ↗

Personalized therapy for non-small cell lung cancer: hype or clinical reality?Semantic proximity Read ↗

Emerging application of genomics-guided therapeutics in personalized lung cancer treatmentSemantic proximity Read ↗

Personalized treatment of lung cancer.Semantic proximity Read ↗

Progress in individualized treatment for EGFR-mutated advanced non-small cell lung cancer.Semantic proximity Read ↗

Current and future targeted therapies for non-small-cell lung cancers with aberrant EGF receptors.Semantic proximity Read ↗

Personalized therapy on the horizon for squamous cell carcinoma of the lung.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.